Bedside implantation of a new temporary vena cava inferior filter - Safety and efficacy results of the European ANGEL-Registry

Pulmonary embolism (PE) is a frequently occurring complication in critically ill patients. Simultaneous occurrence of PE and life-threatening bleeding, may render medical anticoagulation impossible. For these patients, inferior vena cava filters (IVCF) present a valuable therapeutic alternative. The Angel ® catheter is a novel IVCF that provides temporary protection from PE and is implanted at bedside.The primary objective of the European Angel® catheter registry is to evaluate the safety and efficacy of this IVCF.

Source: Journal of Critical Care - October 13, 2017 Category: Intensive Care Authors: Stefan Baumann, Tobias Becher, Konstantinos Giannakopoulos, Claude Jabbour, Marlon Rutsch, Christian Fastner, Ibrahim El-Battrawy, Uzair Ansari, Dirk Lossnitzer, Michael Behnes, Angelika Alonso, Thomas Kirschning, Guido Michels, Daniel Stern, Ruediger Dis Source Type: research